Has anyone figures out what the company is worth with approval, and thus the basic approval price? There has to be some math/calculation to work out the basic price, no?
Abducens' you continue to say as you have done consistently if Both' filters are cleared by the FDA.
I still fail to understand that comment by you.
WE ARE awaiting appproval of One' Device that contains two components,.H2H- and MD220
One will not be approved without the other.
It's an H2H/MD220 Device..
Why do you keep on posting we are waiting on 2 Decisions.. ?
"Upon FDA marketing clearance, Nephros believes that the OLpur H2H will expand the use of HDF as a cost-effective and attractive alternative for ESRD therapy with the OLpur H2H and MDHDF filters representing the first and only FDA-cleared HDF therapy available in the U.S."
Agreed, micron. I think the pps should hit at least 3 dollars if both filters are cleared by the FDA. Long term, I think it will continue higher, if NEPH can show they are increasing revenue with sales.